Director of Institute of Pharmaceutical and Biomedical Sciences and Chair of Department of Pharmaceutical Biology, Johannes Gutenberg University Mainz, Germany
Professor Dr. Prof. h. c. mult. Thomas Efferth is the Director of the Institute of Pharmaceutical and Biomedical Sciences and Chair of the Department of Pharmaceutical Biology at Johannes Gutenberg University Mainz, Germany. He is a trained biologist (Technical University of Darmstadt, Germany) and completed his doctoral thesis at the German Cancer Research Center (DKFZ) in Heidelberg, Germany, (1990). He has received nine national and international scientific awards, including Dr. Willmar-Schwabe-Award of the German Society for Medicinal Plant Research (2006), CESAR Award for Translational Oncology (2011), Qihuang International Award of the Chinese Association of Chinese Medicine (2017), SFE Outstanding International Ethnopharmacologist Award (2021), among others.
He is a member of the Academia Europaea and of the World Academy of Sciences, as well as a fellow of the Royal Society of Medicine (London). He is an honorary and visiting professor at seven international universities. In 2022, he was visiting professor (“professional visitor”) at the McLean Hospital, Harvard Medical School, Boston, USA.
He has published over 900 PubMed-listed papers in peer-reviewed journals in the field of cancer research, pharmacology, and natural products (Hirsch-factor: 125; citation rate: 82,000; according to Google Scholar). He compiled a textbook on “Molecular Pharmacology and Toxicology” (Springer Publisher) and edited several other books.
According to the Stanford University Citation Ranking, he was among the top 2% most-cited authors worldwide. He is editor-in-chief of Phytomedicine and Phytomedicine Plus as well as associate editor of several other pharmaceutical journals. Furthermore, he is a member of several scientific advisory boards. Nineteen of his former lab members have been promoted to leading academic positions (full professors, associate/assistant professors).
Professor Efferth’s research focuses on molecular and network pharmacology of natural and synthetic compounds, bioinformatics, and artificial intelligence.